Scinai Immunotherapeutics Ltd. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/09/2024 | Q2 2024 | -$2.76 | $282,964 | |||
03/30/2024 | Q1 2024 | -$4.27 | $0 | |||
12/30/2023 | Q4 2023 | -$9.63 | $0 | |||
09/29/2023 | Q3 2023 | $25.26 | $0 | |||
06/29/2023 | Q2 2023 | -$12.02 | $0 | |||
03/30/2023 | Q1 2023 | -$12.04 | $0 | |||
12/30/2022 | Q4 2022 | -$13.32 | $0 | |||
09/29/2022 | Q3 2022 | $5.65 | $0 | |||
06/29/2022 | Q2 2022 | -$19.79 | $0 | |||
03/30/2022 | Q1 2022 | -$15.82 | $0 | |||
12/30/2021 | Q4 2021 | -$46.07 | $0 | |||
09/29/2021 | Q3 2021 | -$24.82 | $0 | |||
06/29/2021 | Q2 2021 | -$25.67 | $0 | |||
03/30/2021 | Q1 2021 | -$18.60 | $0 | |||
12/30/2020 | Q4 2020 | -$404.39 | $0 | |||
09/29/2020 | Q3 2020 | $1,644.55 | $0 | |||
06/29/2020 | Q2 2020 | -$1,339.88 | $0 | |||
03/30/2020 | Q1 2020 | -$130.47 | $0 | |||
12/30/2019 | Q4 2019 | -$1,451.38 | $0 | |||
09/29/2019 | Q3 2019 | -$718.27 | $0 |
Scinai Immunotherapeutics Ltd. Earnings: Frequently Asked Questions
-
When is Scinai Immunotherapeutics Ltd.'s earnings date?
Scinai Immunotherapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 26th, 2024 based off last year's report dates.
-
How can I listen to Scinai Immunotherapeutics Ltd.'s earnings conference call?
The conference call for Scinai Immunotherapeutics Ltd.'s latest earnings report can be listened to online.
-
How can I read Scinai Immunotherapeutics Ltd.'s conference call transcript?
The conference call transcript for Scinai Immunotherapeutics Ltd.'s latest earnings report can be read online.
-
How much profit does Scinai Immunotherapeutics Ltd. generate each year?
Scinai Immunotherapeutics Ltd. (:SCNI) has a recorded net income of $0. Scinai Immunotherapeutics Ltd. has generated $-16.69 earnings per share over the last four quarters.
-
What is Scinai Immunotherapeutics Ltd.'s price-to-earnings ratio?
Scinai Immunotherapeutics Ltd. (:SCNI) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.